New medical application of cedrol

A technology of cedrol, use, applied in the field of new use in analgesic and arthritis medicine, to achieve good analgesic and anti-inflammatory effects

Active Publication Date: 2009-09-02
辽宁新中现代医药有限公司
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the side effects of western medicine are increasingly being paid attention to and evaluated by the international community. At the same time, patients' self-protection awa

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New medical application of cedrol
  • New medical application of cedrol
  • New medical application of cedrol

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1: Effects on paw edema and inflammation of rats caused by carrageenan Method: 60 SD rats, body weight: ♀140~176g, 150~180g, ♀ half and half, divided into 6 groups, 10 in each group. The model group was intragastrically administered with 1% TW-80, and 4 dose groups of 100mg / kg, 50mg / kg, 25mg / kg and 10mg / kg of the test drug α-CE were respectively set up, administered intragastrically (ig) once a day, A total of 4 days of administration. Positive control drug is aspirin 0.5g / kg only before the test by intragastric administration (ig) once. After d4ig1h, sc0.5% carrageenan 0.1ml on the right hind paw of the rat. The change of paw volume was measured by capillary method at 1h, 2h, 4h, 6h after sc. The results were statistically processed by computer SigmaStat software, and the significant difference between aspirin and model group (1%TW-80) was compared.

[0027] Result: α-CE25mg / kg, 50mg / kg, 100mg / kg and aspirin 0.5g / kg have significant inhibitory effect on ...

Embodiment 2

[0031] Example 2: Effects on Adjuvant Arthritis in Rats

[0032] Methods: 60 SD rats were taken and divided into 5 groups on average according to body weight: (1) 1% TW-80 (vehicle); (2) positive control drug dexamethasone phosphate injection 2.5 mg / kg; (3) α - CE 25 mg / kg; (4) α-CE 50 mg / kg; (5) α-CE 100 mg / kg. All were administered by intragastric administration (ig). 0.1 ml of complete Freund's adjuvant (containing 0.5 mg of BCG) was injected into the right hind paw. Oral administration once 30 minutes before the injection of adjuvant. 18 hours after the injection of the adjuvant, measure the swelling of the right hind paw, observe the preventive effect of CE on early acute inflammation, and then stop the drug; one week later, start intragastric administration, once a day, for 7 consecutive days, and measure once on d15 Observe the preventive effect of CE on secondary lesions for the swelling of the left hind foot, and then stop the drug; start therapeutic administration...

Embodiment 3

[0047] Example 3: Effects on Tail Flick of Rats Caused by Photothermal Stimulation (Photothermal Analgesia Model)

[0048] Methods: 1) Dose selection and grouping: 1% TW-80 was used as negative control, and indomethacin 10 mg / kg was used as positive control. The mixture of α-CE and β-CE has three dosage groups of 12.5mg / kg, 25mg / kg and 50mg / kg. 10 rats per group, ♀ Half and half were kept in separate cages. 2) Administration: intragastric administration (ig) once, the volume of intragastric administration is 1ml / 100g. 3) Observation: 1 hour after the ig, the tail of the rat was stimulated by light and heat, and the time for the rat to flick the tail was recorded. The results were statistically processed by computer SigmaStat software, and the significant differences were compared between indomethacin, CE and 1% TW-80 groups.

[0049] Results: CE12.5mg / kg, 25mg / kg, 50mg / kg and indomethacin 10mg / kg had significant analgesic effects on the tail of rats stimulated by light an...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to new medical application of cedrol (CE), in particular to new application thereof in preparing medicaments for relieving pain and treating arthritis. The cedrol is alpha-cedrol, beta-CE or raceme of the two in any proportion, and the total effective dose of the cedrol is between 1 and 100 mg/kg/d. The CE is extracted from natural plants extensive in sources. The invention adopts rat-paw chondrus inflammation-inducing method and adjuvant arthritis to observe the anti-inflammatory effects of the CE, and results show that the CE has obvious effect of inhibiting nonspecific inflammation reaction caused by carrageenin and also has remarkable effect of treating and preventing the adjuvant arthritis. The invention adopts a tail-flick method to observe the analgesic effects of the CE, and results show that the CE has remarkable analgesic effects on the light-heat stimulated tails of rats. The invention provides a raw material for anti-inflammatory and analgesic drugs, which is exact in therapeutic effects, safe, convenient and extensive in sources, and can be combined with one or more pharmaceutically acceptable carriers so as to prepare a cedrol pharmaceutical composition or preparation.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to a new medical application of cedrol (CE), in particular to its new application in analgesic and arthritis-treating medicines. Background technique [0002] Arthritis is a common chronic disease, which refers to arthritic lesions caused by inflammation, infection, trauma or other factors, and belongs to rheumatology diseases. Its main features are joint swelling, heat, pain, and dysfunction. It is estimated that there are more than 100 million arthritis patients in my country, and the number is still increasing. The most common types are osteoarthritis and rheumatoid arthritis. According to statistics, half of the people over the age of 50 in my country suffer from osteoarthritis; 90% of the women and 80% of the men over the age of 65 suffer from osteoarthritis. The prevalence of rheumatoid arthritis in my country is 0.34% to 0.36%. According to reports, the life expectancy of pa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/045A61P19/02A61P29/00A61P19/04
Inventor 孙宝山赵余庆关健
Owner 辽宁新中现代医药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products